Zinc transporter (ZnT)8186–194 is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients
暂无分享,去创建一个
G. Bruno | F. Lemonnier | D. Levy | C. Boitard | R. Mallone | G. Afonso | H. Davidson | J. Carel | J. Hutton | J. Gautier | D. Dubois-Laforgue | E. Larger | O. Launay | L. Sechi | B. Baz | C. Raverdy | M. Scotto
[1] Tao Yang,et al. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays , 2012, Autoimmunity.
[2] N. Ahmed,et al. Antibodies Recognizing Mycobacterium avium paratuberculosis Epitopes Cross-React with the Beta-Cell Antigen ZnT8 in Sardinian Type 1 Diabetic Patients , 2011, PloS one.
[3] C. Boitard,et al. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes. , 2011, Endocrine reviews.
[4] Liping Yu,et al. Human Type 1 Diabetes Is Associated with T Cell Autoimmunity to Zinc Transporter 8 , 2011, The Journal of Immunology.
[5] J. Drijfhout,et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. , 2008, The Journal of clinical investigation.
[6] P. van Endert,et al. The Frequency and Immunodominance of Islet-Specific CD8+ T-cell Responses Change after Type 1 Diabetes Diagnosis and Treatment , 2008, Diabetes.
[7] Marian Rewers,et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.
[8] M. Dolz,et al. Immunization of HLA Class I Transgenic Mice Identifies Autoantigenic Epitopes Eliciting Dominant Responses in Type 1 Diabetes Patients1 , 2007, The Journal of Immunology.
[9] M. Dolz,et al. CD8+ T-Cell Responses Identify β-Cell Autoimmunity in Human Type 1 Diabetes , 2007, Diabetes.
[10] H. Luthra,et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis , 1996, The Journal of experimental medicine.